Molecular and spatial transcriptomic classification of midbrain dopamine neurons and their alterations in a LRRK2G2019S model of Parkinson's disease
Zachary A. GaertneriD, Cameron OramiD, Amanda K. SchneeweisiD, Elan SchonfeldiD, Cyril BolduciD, Chuyu CheniD, Daniel A. DombeckiD, Loukia ParisiadouiD, Jean-Francois PouliniD, Rajeshwar B. AwatramaniiD
Abstract
Several studies have revealed that midbrain dopamine (DA) neurons, even within a single neuroanatomical area, display heterogeneous properties. In parallel, studies using single cell profiling techniques have begun to cluster DA neurons into subtypes based on their molecular signatures. Recent work has shown that molecularly defined DA subtypes within the substantia nigra (SNc) display distinctive anatomic and functional properties, and differential vulnerability in Parkinsons disease (PD). Based on these provocative results, a granular understanding of these putative subtypes and their alterations in PD models, is imperative. We developed an optimized pipeline for single-nuclear RNA sequencing (snRNA-seq) and generated a high-resolution hierarchically organized map revealing 20 molecularly distinct DA neuron subtypes belonging to three main families. We integrated this data with spatial MERFISH technology to map, with high definition, the location of these subtypes in the mouse midbrain, revealing heterogeneity even within neuroanatomical sub-structures. Finally, we demonstrate that in the preclinical LRRK2G2019S knock-in mouse model of PD, subtype organization and proportions are preserved. Transcriptional alterations occur in many subtypes including those localized to the ventral tier SNc, where differential expression is observed in synaptic pathways, which might account for previously described DA release deficits in this model. Our work provides an advancement of current taxonomic schemes of the mouse midbrain DA neuron subtypes, a high-resolution view of their spatial locations, and their alterations in a prodromal mouse model of PD. Teaser: Using snRNASeq and MERFISH we identified midbrain DA subtypes, mapped their spatial location, and identified alterations in a LRRK2 model
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 1.80
- Field percentile
- top 17%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell Transcriptomic Atlas of the Human Substantia Nigra in Parkinson's Disease
Qian Wang, Minghui Wang, … Zhenyu Yue·bioRxiv·Mar 25, 2022
- A molecular census of midbrain dopaminergic neurons in Parkinson's disease
Tushar Kamath, Abdulraouf Abdulraouf, … Evan Z. Macosko·bioRxiv·Jun 16, 2021
- Transcriptomic atlas of midbrain dopamine neurons uncovers differential vulnerability in a Parkinsonism lesion model
Behzad Yaghmaeian Salmani, Laura Lahti, … Thomas Perlmann·eLifePeer-reviewed·Aug 14, 2023
- Serotonergic and dopaminergic neurons in the dorsal raphe are differentially altered in a mouse model for parkinsonism.
Laura Boi, Yvonne Johansson, … Gilad Silberberg·eLifePeer-reviewed·Jun 28, 2024
- Single-nucleus and spatial transcriptomic analysis identified molecular features of neuronal heterogeneity and distinct glial responses in Parkinson's disease.
Sooyeon Yoo, Kwanghoon Lee, … Sung‐Hye Park·bioRxiv·Jul 28, 2024
- A Vulnerable Subtype of Dopaminergic Neurons Drives Early Motor Deficits in Parkinson's Disease
Akira Fushiki, David Ng, … Rui M. Costa·bioRxiv·Dec 20, 2024